Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium alginate/bicarbonate/calcium carbonate suspension added to proton pump inhibitor in refractory GERD
IRCT20230629058615N7Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Sodium alginate, sodium bicarbonate and calcium carbonate in refractory gastroesophageal reflux disease (rGERD), sponsored by Islamic Azad University. Started Feb 2025; status: completed.
02
Drugs
Sodium alginatesodium bicarbonatecalcium carbonate
03
Conditions
refractory gastroesophageal reflux disease (rGERD)
Beyond the preview
Go deeper on IRCT20230629058615N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230629058615N7.